MacroGenics Provides Update on Corporate Progress, First Quarter 2024 Financial Results and Interim TAMARACK Phase 2 Study Data
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| MACROGENICS (NASDAQ: MGNX) | Delayed: 2.25 -1.38 (38.02%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.63 | 52 Week High | $36.11 | |||
| Open | $3.55 | 52 Week Low | $14.84 | |||
| Day High | $3.57 | P/E | 5.77 | |||
| Day Low | $2.13 | EPS | $0.39 | |||
| Volume | 4,009,366 | |||||
